Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
Saved in:
| Title: | Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young. |
|---|---|
| Authors: | Fordham AM; Children's Cancer Institute Australia Randwick Australia., Brown LM; Children's Cancer Institute Australia Sydney Australia., Mayoh C; Children's Cancer Institute Australia Sydney, NSW Australia., Salib A; Children's Cancer Institute Australia for Medical Research Sydney, NSW Australia., Barger ZA; Children's Cancer Institute Australia Randwick Australia., Wong M; Children's Cancer Institute Australia Kensington Australia., Lim Kam Sian TCC; Monash University Clayton, Victoria Australia., Hu C; Monash University Clayton Australia., Xie J; Children's Cancer Institute Australia Sydney, NSW Australia., Gunther K; University of New South Wales Sydney, NSW Australia., Trebilcock P; Children's Cancer Institute Australia Randwick Australia., Terry RL; Children's Cancer Institute Australia Randwick Australia., Barahona P; Children's Cancer Institute Australia Sydney, NSW Australia., Ajuyah P; Children's Cancer Institute Australia Sydney, NSW Australia., Sherstyuk A; Thermo Fisher Scientific Sydney, NSW Australia., Avila A; Children's Cancer Institute Australia Kensington, NSW Australia., Cadiz R; Children's Cancer Institute Australia Sydney, NSW Australia., Perkins CM; Children's Cancer Institute Sydney, NSW Australia., Gifford AJ; Children's Cancer Institute Australia Randwick, NSW Australia., Mao J; Children's Cancer Institute Australia Kensington, NSW Australia., Dolman MEM; Children's Cancer Institute Australia Kensington, NSW Australia., Zhao A; Children's Cancer Institute Australia Randwick Australia., O'Regan LP; Children's Cancer Institute Australia Randwick Australia., Gorgels D; KU Leuven Leuven Belgium., Lau LMS; Sydney Children's Hospital Randwick, NSW Australia., Ziegler DS; Sydney Children's Hospital Randwick, NSW Australia., Haber M; Children's Cancer Institute Australia RANDWICK, NSW Australia., Tyrrell V; Children's Cancer Institute Australia Australia., Lock RB; Children's Cancer Institute Australia Sydney, NSW Australia., Cowley MJ; Children's Cancer Institute Australia Randwick, NSW Australia., Nicholls W; Queensland Children's Hospital Brisbane, Queensland Australia., Daly RJ; Monash University Clayton, Victoria Australia., Ekert PG; Children's Cancer Institute Randwick, NSW Australia., Fleuren EDG; Children's Cancer Institute Sydney, NSW Australia. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2026 Mar 19. Date of Electronic Publication: 2026 Mar 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
